Next Article in Journal
Biological Activities and Bioavailability of Mangosteen Xanthones: A Critical Review of the Current Evidence
Next Article in Special Issue
Docosahexaenoic Acid, Inflammation, and Bacterial Dysbiosis in Relation to Periodontal Disease, Inflammatory Bowel Disease, and the Metabolic Syndrome
Previous Article in Journal
Vitamin C: A Novel Regulator of Neutrophil Extracellular Trap Formation
Previous Article in Special Issue
The Relationship of Docosahexaenoic Acid (DHA) with Learning and Behavior in Healthy Children: A Review
Nutrients 2013, 5(8), 3151-3162; doi:10.3390/nu5083151

Impact of Docosahexaenoic Acid on Gene Expression during Osteoclastogenesis in Vitro—A Comprehensive Analysis

*  and
Department of Cellular Physiological Chemistry, Graduate School, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo 113-8549, Japan
* Author to whom correspondence should be addressed.
Received: 28 May 2013 / Revised: 9 July 2013 / Accepted: 1 August 2013 / Published: 13 August 2013
(This article belongs to the Special Issue Docosahexaenoic Acid and Human Health)
View Full-Text   |   Download PDF [473 KB, 14 August 2013; original version 13 August 2013]   |   Browse Figures


Polyunsaturated fatty acids (PUFAs), especially n-3 polyunsaturated fatty acids, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), are known to protect against inflammation-induced bone loss in chronic inflammatory diseases, such as rheumatoid arthritis, periodontitis and osteoporosis. We previously reported that DHA, not EPA, inhibited osteoclastogenesis induced by the receptor activator of nuclear factor-κB ligand (sRANKL) in vitro. In this study, we performed gene expression analysis using microarrays to identify genes affected by the DHA treatment during osteoclastogenesis. DHA strongly inhibited osteoclastogenesis at the late stage. Among the genes upregulated by the sRANKL treatment, 4779 genes were downregulated by DHA and upregulated by the EPA treatment. Gene ontology analysis identified sets of genes related to cell motility, cell adhesion, cell-cell signaling and cell morphogenesis. Quantitative PCR analysis confirmed that DC-STAMP, an essential gene for the cell fusion process in osteoclastogenesis, and other osteoclast-related genes, such as Siglec-15, Tspan7 and Mst1r, were inhibited by DHA.
Keywords: polyunsaturated fatty acid; docosahexaenoic acid; osteoclast polyunsaturated fatty acid; docosahexaenoic acid; osteoclast
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
MDPI and ACS Style

Akiyama, M.; Nakahama, K.-I.; Morita, I. Impact of Docosahexaenoic Acid on Gene Expression during Osteoclastogenesis in Vitro—A Comprehensive Analysis. Nutrients 2013, 5, 3151-3162.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here


Cited By

[Return to top]
Nutrients EISSN 2072-6643 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert